Evaxion A (EVAX) Total Non-Current Liabilities (2021 - 2025)

Evaxion A (EVAX) posted Total Non-Current Liabilities of $7.1 million for Q4 2025, down 34.76% on a QoQ basis from $10.9 million in Q2 2025, and down 27.2% year-over-year from $9.8 million in Q4 2024.

Evaxion A (EVAX) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Evaxion A's Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $7.1 million for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 27.2% year-over-year to $7.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.1 million (down 27.2% YoY) and the FY2025 annual result came in at $7.1 million, down 27.2% from the prior year.
  • Total Non-Current Liabilities was $7.1 million for Q4 2025 at Evaxion A, down from $10.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $10.9 million in Q2 2025 and bottomed at $1.0 million in Q2 2021.
  • A 5-year average of $7.5 million and a median of $9.8 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 819.77% — and 2025, when it decreased 27.2%.
  • Evaxion A's Total Non-Current Liabilities stood at $3.4 million in 2021, then soared by 192.68% to $10.0 million in 2022, then gained by 5.76% to $10.5 million in 2023, then declined by 7.26% to $9.8 million in 2024, then slipped by 27.2% to $7.1 million in 2025.
  • Business Quant data shows EVAX's Total Non-Current Liabilities at $7.1 million in Q4 2025, $10.9 million in Q2 2025, and $9.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Evaxion A 25.44 Mn 25.44 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.11 Mn
Jun 30, 2025 10.90 Mn
Dec 31, 2024 9.77 Mn
Jun 30, 2024 10.16 Mn
Dec 31, 2023 10.53 Mn
Jun 30, 2023 10.17 Mn
Dec 31, 2022 9.96 Mn
Jun 30, 2022 9.45 Mn
Mar 31, 2022 10.01 Mn
Dec 31, 2021 3.40 Mn
Sep 30, 2021 3.54 Mn
Jun 30, 2021 1.03 Mn
Mar 31, 2021 1.11 Mn